NCT00486837View on ClinicalTrials.gov

Deposition of Inhaled Prolastin in Cystic Fibrosis Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Cystic Fibrosis
Interventions
DRUG

Alpha1-Proteinase Inhibitor (Human)

25 mg of Alpha1-Proteinase Inhibitor (Human) in the lungs, one inhalation per day over 4 weeks.

Sponsors
All Listed Sponsors
lead

Grifols Therapeutics LLC

INDUSTRY